L04AA04 • anti-lymphocyte immunoglobulin • Antineoplastic and immunomodulating agents | Immunosuppressants | Selective immunosuppressants
Anti-lymphocyte immunoglobulin is an immunological preparation used for the prevention and treatment of acute rejection in organ transplantation, as well as for the treatment of severe autoimmune conditions. It works by binding to T-lymphocytes, suppressing the body's immune response.
The medication is administered intravenously, as directed by a doctor, and requires careful monitoring for adverse effects.
Side effects may include fever, chills, skin rash, leukopenia, or thrombocytopenia. In rare cases, anaphylactic reactions or severe infections may occur.
Anti-lymphocyte immunoglobulin is not recommended for patients with hypersensitivity to this medication or active severe infections.
Substance: anti-lymphocyte immunoglobulin
Date of last drug list: 01-07-2015
Commercial code: W61725002
Concentration: 20mg / ml
Pharmaceutical form: concentrate for injection
Packing volume: 10 ml
Product type: original
Prescription restrictions: S - Medicines prescription reserved for use in certain specialized fields.
Manufacturer: NEOVII BIOTECH GMBH - GERMANIA
Holder: NEOVII BIOTECH GMBH - GERMANIA
Number: 7711/2015/02
Shelf life: 2 years